RNA vs TYRA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

RNA

53.9
AI Score
VS
RNA Wins

TYRA

46.2
AI Score

Investment Advisor Scores

RNA

54score
Recommendation
HOLD

TYRA

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric RNA TYRA Winner
Net Income -16.63M -39.30M RNA
Operating Income -17.28M -42.00M RNA
ROE -7.1% -10.1% RNA
ROA -5.7% -9.5% RNA
Total Assets 292.36M 412.04M TYRA
Cash 267.85M 84.95M RNA
Current Ratio 13.04 20.49 TYRA
Free Cash Flow -33.24M -32.66M TYRA

Relative Price Performance (Last 90 Days)

RNA 1M: -14.7% · 3M: -11.1% TYRA 1M: +8.4% · 3M: -8.3%

Current Technical Phase

RNA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.1%), weak momentum, RSI 37

RSI (14): 37.0 · Price: $11.35

TYRA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.5 · Price: $31.88

Fundamentals Snapshot

Metric RNA TYRA
Market Cap
Forward P/E -1.9 -11.2
Trailing P/E
Revenue (TTM)
Revenue Growth 11.5% 0.0%
Gross Margin -0.3%
Operating Margin -0.9% 0.0%
EPS -5.02 -2.32
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, RNA is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.